Article Data

  • Views 445
  • Dowloads 112

Original Research

Open Access

Biological and pathological features in pregnancy-associated breast cancer: a matched case-control study

  • S. Baulies1,*,
  • M. Cusidó1
  • F. Tresserra2
  • F. Fargas1
  • I. Rodríguez3
  • B. Úbeda4
  • C. Ara1
  • R. Fábregas1

1Gynecologic Oncology and Breast Pathology Section, Department of Obstetrics, Gynecology and Human Reproduction Hospital Universitari Quirón Dexeus, Barcelona, Spain

2Department of Pathology, Department of Obstetrics, Gynecology and Human Reproduction Hospital Universitari Quirón Dexeus, Barcelona, Spain

3Statistics and Epidemiology Unit, Department of Obstetrics, Gynecology and Human Reproduction Hospital Universitari Quirón Dexeus, Barcelona, Spain

4Gynecologic Diagnostic Imaging, Department of Obstetrics, Gynecology and Human Reproduction Hospital Universitari Quirón Dexeus, Barcelona, Spain

DOI: 10.12892/ejgo2632.2015 Vol.36,Issue 4,August 2015 pp.420-423

Published: 10 August 2015

*Corresponding Author(s): S. Baulies E-mail: sonbau@dexeus.com

Abstract

Background: The prognosis for breast cancer has been considered to be worsened by the coexistence of pregnancy. However, to date, significant controversy still exists regarding the pathological tumor features and prognosis of patients diagnosed with pregnancy-associated breast cancer (PABC). The aim of the present study was to analyze the different prognostic factors and outcome in PABC subset versus a non-PABC control group matched for age and year of diagnosis. Materials and Methods: A total of 56 PABC cases were diagnosed from 1990 to 2008, for whom 73 non-PABC patients were identified. Pathological characteristics, immunohistochemical features, and differences in overall and disease-free survival were compared between both groups. Results: Compared to non-PABC controls, PABC patients presented more advanced disease (31% vs 13%, p = 0.024) and greater lymph node involvement (53% vs 34%, p = 0.034). Pathological and tumor features tended to present poorer prognostic factors in the PABC subset. Survival was poorer in the PABC patients (five-year DFS 68% in PABC vs 86% in non-PABC, p = 0.12). However, analysing survival adjusted for stage and age, the authors did not find significant differences between both groups. Conclusions: PABC patients tended to be diagnosed in advanced breast disease and presented tumors with adverse pathological prognostic factors. While the authors found a poorer outcome in PABC group, no significant differences were observed with stage-matched analysis. The present results may suggest that the poorer prognosis observed within PABC women could not be due to pregnancy itself, but with a delay in diagnosis and tumor subtype pathological features.

Keywords

Breast cancer; Pregnancy; Prognostic factors; Outcome; Pathological features.

Cite and Share

S. Baulies,M. Cusidó,F. Tresserra,F. Fargas,I. Rodríguez,B. Úbeda,C. Ara,R. Fábregas. Biological and pathological features in pregnancy-associated breast cancer: a matched case-control study. European Journal of Gynaecological Oncology. 2015. 36(4);420-423.

References

[1] Johansson A.L., Andersson T.M., Hsieh C.C., Cnattingius S., Lambe M.: “Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum”. Cancer Epidemiol. Biomarkers Prev., 2011, 20, 1865.

[2] Britt K., Ashworth A., Smalley M.: “Pregnancy and the risk of breast cancer”. Endocr. Relat. Cancer, 2007, 14, 907.

[3] Anderson J.M.: “Mammary cancers and pregnancy”. Br. Med. J., 1979, 1, 1124.

[4] Danforth D.N. Jr.: “Breast cancer during pregnancy: a comprehensive review”. Cancer J., 2010, 16, 68.

[5] Murphy C.G., Mallam D., Stein S., Patil S., Howard J., Sklarin N., et al.: “Current or recent pregnancy is associated with adverse pathological features but not impaired survival in early breast cancer”. Cancer, 2012, 118, 3254.

[6] Ribeiro G., Jones D.A., Jones “.: :Carcinoma of the breast associated with pregnancy”. Br. J. Surg., 1986, 73, 607.

[7] Daling J.R., Malone K.E., Doody D.R., Anderson B.O., Porter P.L.: “The relation of productive factors to mortality from breast cancer”. Cancer Epidemiol. Biomarkers Prev., 2002, 11, 235.

[8] Jacobsen B.M., Schittone S.A., Richer J.K., Horwitz K.B.: “Progesterone- independent effects of human progesterone receptors in estrogen receptor-positive breast cancer”. Mol. Endocrinol., 2005, 19, 574.

[9] Schedin P.: “Pregnancy-associated breast cancer and metastasis”. Nat. Rev. Cancer, 2006, 6, 281.

[10] Hanahan D., Weinberg R.: “The Hallmarks of cancer”. Cell, 2000, 100, 57.

[11] Guinee V.F., Olsson H., Moller T., Hess K.R., Taylor S.H., Fahey T., et al.: “Effect of pregnancy on prognosis for young women with breast cancer”. Lancet, 1994, 343, 1587.

[12] Theriault R., Hahn K.: “Management of breast cancer in pregnancy”. Curr. Oncol. Rep., 2007, 9, 17.

[13] Donegan W.L.: “Breast carcinoma and pregnancy”. In: Donegan W.L., Spratt J.S., (eds). Cancer of the breast, 4th ed. Philadelphia:PA: Saunders, 1995, 732.

[14] Johansson A.L., Andersson T.M.L., Hsieh C.C., Jirström K., Dickman P., Cnattingius S., et al.: “Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC)”. Breast Cancer Res. Treat., 2013, 139, 183.

[15] Azim H.A. Jr. , Botteri E., Renne G., Dell’Orto P., Rotmensz N., Gentilini O., et al.: “The biological features and prognosis of breast cancer diagnosed during pregnancy: a case-control study”. Acta Oncol., 2012, 51, 653.

[16] Azim H.A. Jr., Santoro L., Russell-Edu W., Pentheroudakis G., Pavlidis N., Peccatori F.A.: “Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies”. Cancer Treat. Rev., 2012, 38, 834.

[17] Amant F.,Von Minckwitz G., Han S.N., Botenbal M., Ring A.E., Giermerk J., et al.: “Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study”. J. Clin. Oncol., 2013, 20, 2532.

[18] Elston C.W., Ellis I.O.: “Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up”. Histopathology, 1991, 19, 403.

[19] Haagensen C.D., Stout A.P.: “Carcinoma of the breast: II. Criteria of operability”. Ann. Surg., 1943, 118, 859.

[20] Theriault R., Hahn K.: “Management of breast cancer in pregnancy”. Curr. Oncol. Rep., 2007, 9, 17.

[21] Middleton L.P., Amin M., Gwyn K., Theriault R., Sahin A.: “Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features”. Cancer, 2003, 98, 1055.

[22] Halaska M.J., Pentheroudakis G., Strnad P., Stankusova H., Chod J., Robova H., et al.: “Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled study”. Breast J., 2009, 15, 461.

[23] Beadle B.M., Woodward W.A., Middleton L.P., Tereffe W., Strom E.A., Litton J.K., et al.: “The impact of pregnancy on breast cancer outcomes in women <or=35 years”. Cancer, 2009, 115, 1174.

[24] Rodriguez A.O., Chew H., Cress R., Xing G., McElvy S., Danielsen B., et al.: “Evidence of poorer survival in pregnancy-associated breast cancer”. Obstet. Gynecol., 2008, 112, 71.

[25] Merino M.J., Middleton L.P., Grases P.J., Tresserra F.: “Breast cancer and pregnancy”. Lab Inv., 1996, 74, 20A.

[26] Shannon C., Smith I.E.: “Breast cancer in adolescents and young women”. Eur. J. Cancer, 2003, 39, 2632.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top